BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tribble JR, Otmani A, Sun S, Ellis SA, Cimaglia G, Vohra R, Jöe M, Lardner E, Venkataraman AP, Domínguez-Vicent A, Kokkali E, Rho S, Jóhannesson G, Burgess RW, Fuerst PG, Brautaset R, Kolko M, Morgan JE, Crowston JG, Votruba M, Williams PA. Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction. Redox Biol 2021;43:101988. [PMID: 33932867 DOI: 10.1016/j.redox.2021.101988] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng C, Liu S, Zhang X, Hu Y, Shang X, Zhu Z, Huang Y, Wu G, Xiao Y, Du Z, Liang Y, Chen D, Zang S, Hu Y, He M, Zhang X, Yu H. Shared genetic architecture between the two neurodegenerative diseases: Alzheimer’s disease and glaucoma. Front Aging Neurosci 2022;14:880576. [DOI: 10.3389/fnagi.2022.880576] [Reference Citation Analysis]
2 Santana-Garrido Á, Reyes-Goya C, Arroyo-Barrios A, André H, Vázquez CM, Mate A. Hypertension secondary to nitric oxide depletion produces oxidative imbalance and inflammatory/fibrotic outcomes in the cornea of C57BL/6 mice. J Physiol Biochem 2022. [PMID: 35943663 DOI: 10.1007/s13105-022-00916-2] [Reference Citation Analysis]
3 Pappenhagen N, Yin E, Morgan AB, Kiehlbauch CC, Inman DM. Stretch stress propels glutamine dependency and glycolysis in optic nerve head astrocytes. Front Neurosci 2022;16:957034. [DOI: 10.3389/fnins.2022.957034] [Reference Citation Analysis]
4 Vallabh NA, Armstrong J, Czanner G, Mc Donagh B, Choudhary A, Criddle DN, Willoughby CE. Evidence of impaired mitochondrial cellular bioenergetics in ocular fibroblasts derived from glaucoma patients. Free Radic Biol Med 2022:S0891-5849(22)00483-X. [PMID: 35872337 DOI: 10.1016/j.freeradbiomed.2022.07.009] [Reference Citation Analysis]
5 Beirowski B. Emerging evidence for compromised axonal bioenergetics and axoglial metabolic coupling as drivers of neurodegeneration. Neurobiol Dis 2022;:105751. [PMID: 35569720 DOI: 10.1016/j.nbd.2022.105751] [Reference Citation Analysis]
6 Tribble JR, Kastanaki E, Uslular AB, Rutigliani C, Enz TJ, Williams PA. Valproic Acid Reduces Neuroinflammation to Provide Retinal Ganglion Cell Neuroprotection in the Retina Axotomy Model. Front Cell Dev Biol 2022;10:903436. [DOI: 10.3389/fcell.2022.903436] [Reference Citation Analysis]
7 Guo Z, Yang J, Yang G, Feng T, Zhang X, Chen Y, Feng R, Qian Y. Effects of nicotinamide on follicular development and the quality of oocytes. Reprod Biol Endocrinol 2022;20:70. [PMID: 35448997 DOI: 10.1186/s12958-022-00938-x] [Reference Citation Analysis]
8 Wu J, Xu M, Liu W, Huang Y, Wang R, Chen W, Feng L, Liu N, Sun X, Zhou M, Qian K. Glaucoma Characterization by Machine Learning of Tear Metabolic Fingerprinting. Small Methods 2022;:e2200264. [PMID: 35388987 DOI: 10.1002/smtd.202200264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhang S, Zhao J, Quan Z, Li H, Qing H. Mitochondria and Other Organelles in Neural Development and Their Potential as Therapeutic Targets in Neurodegenerative Diseases. Front Neurosci 2022;16:853911. [DOI: 10.3389/fnins.2022.853911] [Reference Citation Analysis]
10 Dias MS, Luo X, Ribas VT, Petrs-Silva H, Koch JC. The Role of Axonal Transport in Glaucoma. Int J Mol Sci 2022;23:3935. [PMID: 35409291 DOI: 10.3390/ijms23073935] [Reference Citation Analysis]
11 Hunt SV, Jamison A, Malhotra R. Oral nicotinamide for non-melanoma skin cancers: A review. Eye. [DOI: 10.1038/s41433-022-02036-z] [Reference Citation Analysis]
12 Taechameekietichai T, Chansangpetch S, Peerawaranun P, Lin SC. Association between Daily Niacin Intake and Glaucoma: National Health and Nutrition Examination Survey. Nutrients 2021;13:4263. [PMID: 34959814 DOI: 10.3390/nu13124263] [Reference Citation Analysis]
13 De Moraes CG, John SWM, Williams PA, Blumberg DM, Cioffi GA, Liebmann JM. Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial. JAMA Ophthalmol 2021. [PMID: 34792559 DOI: 10.1001/jamaophthalmol.2021.4576] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
14 Ramulu PY. Neuroprotective Therapies for Patients With Worsening Glaucoma Despite Adequate Intraocular Pressure Lowering-Short-term Neurorecovery, Long-term Neuroprotection? JAMA Ophthalmol 2021. [PMID: 34792548 DOI: 10.1001/jamaophthalmol.2021.4573] [Reference Citation Analysis]
15 Villarejo-Zori B, Jiménez-Loygorri JI, Zapata-Muñoz J, Bell K, Boya P. New insights into the role of autophagy in retinal and eye diseases. Mol Aspects Med 2021;:101038. [PMID: 34620506 DOI: 10.1016/j.mam.2021.101038] [Reference Citation Analysis]
16 Storgaard L, Tran TL, Freiberg JC, Hauser AS, Kolko M. Glaucoma Clinical Research: Trends in Treatment Strategies and Drug Development. Front Med (Lausanne) 2021;8:733080. [PMID: 34589504 DOI: 10.3389/fmed.2021.733080] [Reference Citation Analysis]
17 Li X, Cai S, He Z, Reilly J, Zeng Z, Strang N, Shu X. Metabolomics in Retinal Diseases: An Update. Biology (Basel) 2021;10:944. [PMID: 34681043 DOI: 10.3390/biology10100944] [Reference Citation Analysis]
18 Enz TJ, Tribble JR, Williams PA. Comparison of Glaucoma-Relevant Transcriptomic Datasets Identifies Novel Drug Targets for Retinal Ganglion Cell Neuroprotection. J Clin Med 2021;10:3938. [PMID: 34501387 DOI: 10.3390/jcm10173938] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Tang J, Zhuo Y, Li Y. Effects of Iron and Zinc on Mitochondria: Potential Mechanisms of Glaucomatous Injury. Front Cell Dev Biol 2021;9:720288. [PMID: 34447755 DOI: 10.3389/fcell.2021.720288] [Reference Citation Analysis]
20 Hurley DJ, Irnaten M, O'Brien C. Metformin and Glaucoma-Review of Anti-Fibrotic Processes and Bioenergetics. Cells 2021;10:2131. [PMID: 34440899 DOI: 10.3390/cells10082131] [Reference Citation Analysis]
21 Tezel G. Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets. Prog Retin Eye Res 2021;:100998. [PMID: 34348167 DOI: 10.1016/j.preteyeres.2021.100998] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
22 Petriti B, Williams PA, Lascaratos G, Chau KY, Garway-Heath DF. Neuroprotection in Glaucoma: NAD+/NADH Redox State as a Potential Biomarker and Therapeutic Target. Cells 2021;10:1402. [PMID: 34198948 DOI: 10.3390/cells10061402] [Cited by in F6Publishing: 1] [Reference Citation Analysis]